LFMD LifeMD, Inc.
Services-Offices & Clinics of Doctors of Medicine · Nasdaq · SEC CIK 948320 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-2.6%
TTM net income YoY95.6%
TTM EPS YoY91.2%
Revenue 3-yr CAGR3.2%
Net income 3-yr CAGR—
Margins
Gross margin84.1%
Operating margin-17.9%
Net margin-0.3%
FCF margin-7.5%
EBITDA margin-17.2%
Returns
ROE-125.9%
ROA-0.7%
ROIC (approx.)—
Asset turnover2.26x
Leverage & solvency
Liabilities / assets100.9%
Debt / equity—
Current ratio0.80x
Interest coverage92.33x
Cash quality & payout
Operating cash flow / net income23.16x
Accruals ratio15.5%
Payout ratio—
Capex / revenue0.3%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $44.63M | $47.28M | $50.16M | $7.08M | $47.73M | $49.02M | $50.89M | $5.49M |
| Cost of revenue | $8.25M | $5.28M | $5.93M | $4.23M | $7.06M | $6.84M | $8.14M | $9.43M |
| Gross profit | $36.38M | $42.00M | $44.24M | $2.85M | $40.67M | $42.18M | $42.75M | -$1.32M |
| SG&A expense | $14.65M | $13.65M | $15.18M | $6.73M | $13.80M | $14.44M | $14.34M | $6.79M |
| Operating income | -$4.47M | -$7.13M | -$8.93M | -$6.22M | -$3.13M | -$2.35M | -$1.18M | -$5.97M |
| Interest expense | $3,212 | -$45,660 | -$56,476 | -$190,791 | $260,621 | $660,787 | $463,638 | $614,074 |
| Pretax income | -$4.47M | -$7.08M | -$8.87M | -$6.03M | -$4.54M | -$3.01M | -$1.65M | -$6.58M |
| Income tax | — | — | — | -$123,413 | $31,823 | — | — | $169,477 |
| Net income | -$4.47M | -$7.08M | -$8.87M | $19.96M | -$3.89M | -$1.62M | -$183,778 | -$4.94M |
| EBITDA | -$4.17M | -$6.84M | -$8.64M | -$5.97M | -$2.87M | -$2.17M | -$1.03M | -$5.80M |
| EPS (basic) | -0.11 | -0.16 | -0.20 | — | -0.10 | -0.05 | -0.02 | — |
| EPS (diluted) | -0.11 | -0.16 | -0.20 | — | -0.10 | -0.05 | -0.02 | — |
| Weighted avg. shares (diluted) | 48.18M | 47.79M | 47.34M | — | 46.16M | 44.40M | 43.14M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $21.92M | $25.14M | $34.48M | $36.79M | $20.95M | $33.01M | $31.95M | $32.65M |
| Receivables | $13.25M | $11.26M | $9.86M | $2.49M | $9.24M | $7.33M | $10.19M | $10.46M |
| Inventory | $10.35M | $2.96M | $3.18M | $2.77M | $3.43M | $3.25M | $2.97M | $2.80M |
| Current assets | $49.26M | $42.08M | $51.70M | $45.01M | $41.09M | $49.03M | $49.97M | $52.37M |
| PP&E, net | $1.91M | $2.04M | $2.26M | $2.44M | $2.58M | $2.05M | $1.44M | $1.44M |
| Intangibles | $166,583 | $198,500 | $230,417 | $262,334 | $1.56M | $1.83M | $1.79M | $53,336 |
| Total assets | $66.29M | $59.89M | $70.12M | $63.59M | $65.98M | $73.56M | $73.61M | $76.10M |
| Current liabilities | $61.70M | $46.61M | $49.59M | $39.58M | $56.66M | $63.53M | $60.90M | $67.40M |
| Long-term debt | — | — | — | — | — | $15.90M | — | — |
| Total debt | — | — | — | — | — | $15.90M | — | — |
| Total liabilities | $66.86M | $51.93M | $55.09M | $45.26M | $62.62M | $73.18M | $74.01M | $83.65M |
| Shareholders' equity | -$579,655 | $7.97M | $15.04M | $18.33M | $1.31M | -$1.78M | -$2.33M | -$9.08M |
| Net debt | — | — | — | — | — | -$17.11M | — | — |
| Shares outstanding | 48.26M | 47.82M | 47.53M | 46.66M | 46.58M | 45.04M | 43.53M | 42.19M |
| Cash flow statement | ||||||||
| Operating cash flow | -$949,634 | -$6.93M | $444,624 | -$3.28M | -$147,136 | $8.64M | $3.07M | $1.07M |
| Capital expenditure | $170,728 | $67,825 | $105,178 | $155,454 | $785,748 | $776,670 | $117,545 | $225,410 |
| Free cash flow | -$1.12M | -$6.99M | $339,446 | -$3.44M | -$932,884 | $7.86M | $2.95M | $847,891 |
| Investing cash flow | -$1.49M | -$1.63M | -$2.06M | $17.07M | -$3.59M | -$3.70M | -$2.87M | -$2.72M |
| Financing cash flow | -$776,563 | -$776,562 | -$696,043 | -$788,562 | -$8.70M | -$3.10M | -$812,563 | -$934,903 |
| Depreciation & amortization | $301,000 | $293,000 | $289,458 | $255,955 | $253,000 | $176,000 | $155,361 | $166,278 |
| Stock-based compensation | $1.68M | $790,112 | $1.45M | $2.66M | $3.20M | $2.09M | $2.55M | $3.10M |
| Dividends paid | $776,563 | $776,562 | $776,563 | $776,562 | $776,563 | $776,562 | $776,563 | $776,562 |
| Share buybacks | — | — | — | — | $270,000 | — | — | — |
Free plan shows the latest 8 periods; Pro shows all 59 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.